Idera Pharmaceuticals Inc

Company Snapshot
505 Eagleview Boulevard
Exton, PA 19341
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 36
https://www.iderapharma.com
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
Operating Income
($36,687,000)
($26,351,000)
($19,539,000)
Net Income
($112,662,000)
$98,091,000
($23,360,000)
2020
Gross Profit
Operating Income
($36,687,000)
Net Income
($112,662,000)
2021
Gross Profit
Operating Income
($26,351,000)
Net Income
$98,091,000
2022
Gross Profit
Operating Income
($19,539,000)
Net Income
($23,360,000)
The above data on Idera Pharmaceuticals Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
John Kirby
Senior Vice President Chief Financial Officer and Principal Accounting Officer
$517,438
$45,670
$295,633
$858,741
John Kirby
$858,741
Senior Vice President Chief Financial Officer and Principal Accounting Officer
John Taylor
Chief Executive Officer, President and Director
$212,170
$0
$9,019
$221,189
John Taylor
$221,189
Chief Executive Officer, President and Director
Michael Dougherty
Independent Director
$80,563
$8,869
$0
$89,432
Michael Dougherty
$89,432
Independent Director
Cristina Csimma
Independent Director
$51,250
$8,869
$0
$60,119
Cristina Csimma
$60,119
Independent Director
Ronald Wooten
Independent Director
$11,875
$0
$0
$11,875
Ronald Wooten
$11,875
Independent Director
Idera Pharmaceuticals Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us